Back to Results
First PageMeta Content
Radiation oncology / Radioactivity / Medical physics / Nuclear physics / Radioimmunotherapy / Ibritumomab tiuxetan / Radiation therapy / Dosimetry / Ionizing radiation / Medicine / Physics / Radiobiology


Radioimmunotherapy Dosimetry William D. Erwin, M.S. Department of Imaging Physics UT M. D. Anderson Cancer Center Radioimmunotherapy
Add to Reading List

Document Date: 2005-10-18 14:16:03

Open Document

File Size: 3,05 MB

Share Result on Facebook

Company

Target / mCi / /

Event

FDA Phase / /

IndustryTerm

therapy of cancer / e-’ / /

MedicalCondition

Other cancers / tumor / Astrocytomas / cancer / tumors / Non-Hodgkin’s B-Cell Lymphoma 90Y-Zevalin™ / GI Gliomas / investigation Other Lymphomas / /

MedicalTreatment

radiation therapy / Radioimmunotherapy / radiation / /

Organization

FDA / M.S. Department of Imaging Physics UT M. D. Anderson Cancer Center Radioimmunotherapy Localized / /

Person

Radioimmunotherapy Dosimetry / William D. Erwin / /

Product

Zevalin / BEXXAR / /

Technology

radiation / antibodies / /

URL

www.idecpharm.com/site/science/zevalin_pi.pdf / www.corixa.com/BEXXAR/bexxarpackageinsert.pdf / /

SocialTag